Medicare BALANCE Obesity Drug Pilot Collapses
Medicare's BALANCE obesity drug pilot has failed after insurers declined to join, forcing the government to seek alternative GLP-1 coverage paths.
GLP-1
3 articles tagged "GLP-1"
Eli Lilly's Retatrutide Cuts Blood Sugar & Weight in Trial
Eli Lilly's triple-G drug retatrutide showed significant HbA1C and weight reductions in type 2 diabetes patients at 40 weeks in a 2026 late-stage trial.
FDA Targets Telehealth GLP-1 Compounders in 2026 Crackdown
FDA has warned 70+ telehealth companies over compounded GLP-1 drugs, with scrutiny now extending to affiliated medical groups and prescribing networks.
By Robert Kim